Attached files
| file | filename |
|---|---|
| EX-32.1 - SEELOS THERAPEUTICS, INC. | v222167_ex32-1.htm |
| EX-31.1 - SEELOS THERAPEUTICS, INC. | v222167_ex31-1.htm |
| EX-31.2 - SEELOS THERAPEUTICS, INC. | v222167_ex31-2.htm |
| 10-Q - SEELOS THERAPEUTICS, INC. | v222167_10q.htm |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Mark Westgate, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Apricus Biosciences, Inc. on Form 10-Q for the quarter ended March 31, 2011, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Apricus Biosciences, Inc.
|
Date: May 13, 2011
|
By:
|
/s/ MARK WESGATE
|
|
Name
|
Mark Westgate
|
|
|
Title:
|
Chief Financial Officer
|